Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE-knockout mice

FASEB Journal

Volumn 28, Issue 3, 2014, Pages 1198-1209

  Zurkinden, Line ^a,b   Solcà, Curzio ^a   Vögeli, Isabelle A ^a,b   Vogt, Bruno ^a   Ackermann, Daniel ^a   Erickson, Sandra K ^c   Frey, Felix J ^a   Sviridov, Dmitri ^d   Escher, Geneviève ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

27 hydroxycholesterol; CYP3A11; LDL VLDL fraction

Indexed keywords

APOLIPOPROTEIN E; ASPARTATE AMINOTRANSFERASE; BILE ACID; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ESTER; CYTOCHROME P450; CYTOCHROME P450 3A; CYTOCHROME P450 3A11; CYTOCHROME P450 8B1; FARNESOID X RECEPTOR; FATTY ACID SYNTHASE; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CYP27A1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BILE ACID METABOLISM; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DETOXIFICATION; DIET; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FECES LEVEL; GENE DOSAGE; GENE EXPRESSION; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATOMEGALY; HETEROZYGOSITY; HISTOLOGY; LIPID ABSORPTION; LIVER LEVEL; LIVER WEIGHT; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; URINARY EXCRETION; WESTERN DIET; 27-HYDROXYCHOLESTEROL; ANIMAL; ATHEROSCLEROSIS; BODY FLUID; GENETICS; KNOCKOUT MOUSE; LDL/VLDL FRACTION; METABOLISM;

27-HYDROXYCHOLESTEROL; CYP3A11; LDL/VLDL FRACTION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BODY FLUIDS; CHOLESTANETRIOL 26-MONOOXYGENASE; GENE DOSAGE; GENOTYPE; MICE; MICE, KNOCKOUT;

EID: 84899545037     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-233791     Document Type: Article

References (32)

1. Norlin, M., von Bahr, S., Bjorkhem, I., and Wikvall, K. (2003) On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation. J. Lipid Res. 44, 1515-1522
2. Cali, J. J., Hsieh, C. L., Francke, U., and Russell, D. W. (1991) Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 266, 7779-7783
3. Bjorkhem, I. (1992) Mechanism of degradation of the steroid side chain in the formation of bile acids. J. Lipid Res. 33, 455-471
4. Russell, D. W., and Setchell, K. D. (1992) Bile acid biosynthesis. Biochemistry 31, 4737-4749
5. Escher, G., Krozowski, Z., Croft, K. D., and Sviridov, D. (2003) Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux. J. Biol. Chem. 278, 11015-11019
6. Mukhamedova, N., Escher, G., D'Souza, W., Tchoua, U., Grant, A., Krozowski, Z., Bukrinsky, M., and Sviridov, D. (2008) Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo. J. Lipid Res. 49, 2312-2322
7. Babiker, A., Andersson, O., Lund, E., Xiu, R. J., Deeb, S., Reshef, A., Leitersdorf, E., Diczfalusy, U., and Bjorkhem, I. (1997) Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism: comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 272, 26253-26261
8. Monson, D. M., DeBarber, A. E., Bock, C. J., Anadiotis, G., Merkens, L. S., Steiner, R. D., and Stout, A. U. (2011) Cerebrotendinous xanthomatosis: a treatable disease with juvenile cataracts as a presenting sign. Arch. Ophthalmol. 129, 1087-1088
9. Rafiq, M., Sharrack, N., Shaw, P. J., and Hadjivassiliou, M. (2011) A neurological rarity not to be missed: cerebrotendinous xanthomatosis. Pract. Neurol. 11, 296-300
10. Reichwaldt, I., Zustin, J., Wenke, K., and Ridderbusch, I. (2010) Differential diagnosis of tendon tumors: xanthomas caused by hyperlipidemia in children. J. Pediatr. Surg. 45, e9-e12
11. Bjorkhem, I., and Hansson, M. (2010) Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem. Biophys. Res. Commun. 396, 46-49
12. Repa, J. J., Lund, E. G., Horton, J. D., Leitersdorf, E., Russell, D. W., Dietschy, J. M., and Turley, S. D. (2000) Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia: reversal by cholic acid feeding. J. Biol. Chem. 275, 39685-39692
13. Rosen, H., Reshef, A., Maeda, N., Lippoldt, A., Shpizen, S., Triger, L., Eggertsen, G., Bjorkhem, I., and Leitersdorf, E. (1998) Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J. Biol. Chem. 273, 14805-14812
14. Dubrac, S., Lear, S. R., Ananthanarayanan, M., Balasubramaniyan, N., Bollineni, J., Shefer, S., Hyogo, H., Cohen, D. E., Blanche, P. J., Krauss, R. M., Batta, A. K., Salen, G., Suchy, F. J., Maeda, N., and Erickson, S. K. (2005) Role of CYP27A in cholesterol and bile acid metabolism. J. Lipid Res. 46, 76-85
15. Bavner, A., Shafaati, M., Hansson, M., Olin, M., Shpitzen, S., Meiner, V., Leitersdorf, E., and Bjorkhem, I. (2010) On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase. J. Lipid Res. 51, 2722-2730
16. Bjorkhem, I. (1994) Inborn errors of metabolism with consequences for bile acid biosynthesis: a minireview. Scand. J. Gastroenterol. Suppl. 204, 68-72
17. Burkard, I., Rentsch, K. M., and von Eckardstein, A. (2004) Determination of 24S-And 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry. J. Lipid Res. 45, 776-781
18. Quattropani, C., Vogt, B., Odermatt, A., Dick, B., Frey, B. M., and Frey, F. J. (2001) Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis. J. Clin. Invest. 108, 1299-1305
19. Locket, P. L., and Gallaher, D. D. (1989) An improved procedure for bile acid extraction and purification and tissue distribution in the rat. Lipids 24, 221-223
20. Erickson, S. K., Lear, S. R., Deane, S., Dubrac, S., Huling, S. L., Nguyen, L., Bollineni, J. S., Shefer, S., Hyogo, H., Cohen, D. E., Shneider, B., Sehayek, E., Ananthanarayanan, M., Balasubramaniyan, N., Suchy, F. J., Batta, A. K., and Salen, G. (2003) Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice. J. Lipid Res. 44, 1001-1009
21. Brown, J., III, Theisler, C., Silberman, S., Magnuson, D., Gottardi-Littell, N., Lee, J. M., Yager, D., Crowley, J., Sambamurti, K., Rahman, M. M., Reiss, A. B., Eckman, C. B., and Wolozin, B. (2004) Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279, 34674-34681
22. Omarova, S., Charvet, C. D., Reem, R. E., Mast, N., Zheng, W., Huang, S., Peachey, N. S., and Pikuleva, I. A. (2012) Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis. J. Clin. Invest. 122, 3012-3023
23. Diekstra, F. P., Saris, C. G., van Rheenen, W., Franke, L., Jansen, R. C., van Es, M. A., van Vught, P. W., Blauw, H. M., Groen, E. J., Horvath, S., Estrada, K., Rivadeneira, F., Hofman, A., Uitterlinden, A. G., Robberecht, W., Andersen, P. M., Melki, J., Meininger, V., Hardiman, O., Landers, J. E., Brown, R. H., Jr., Shatunov, A., Shaw, C. E., Leigh, P. N., Al-Chalabi, A., Ophoff, R. A., van den Berg, L. H., and Veldink, J. H. (2012) Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS ONE 7, e35333
24. Mateos, L., Ismail, M. A., Gil-Bea, F. J., Schule, R., Schols, L., Heverin, M., Folkesson, R., Bjorkhem, I., and Cedazo-Minguez, A. (2011) Side chain-oxidized oxysterols regulate the brain renin-Angiotensin system through a liver X receptor-dependent mechanism. J. Biol. Chem. 286, 25574-25585
25. Dias, V., and Ribeiro, V. (2011) Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism. J. Pharm. Bioallied Sci. 3, 453-459
26. Goodwin, B., Gauthier, K. C., Umetani, M., Watson, M. A., Lochansky, M. I., Collins, J. L., Leitersdorf, E., Mangelsdorf, D. J., Kliewer, S. A., and Repa, J. J. (2003) Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc. Natl. Acad. Sci. U. S. A. 100, 223-228
27. Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., Malunowicz, E., White, P. C., Hewison, M., Mason, P. J., Connell, J. M., Shackleton, C. H., and Stewart, P. M. (2003) Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat. Genet. 34, 434-439
28. Honda, A., Salen, G., Matsuzaki, Y., Batta, A. K., Xu, G., Hirayama, T., Tint, G. S., Doy, M., and Shefer, S. (2005) Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis. J. Lipid Res. 46, 287-296
29. Stone, B. G., Erickson, S. K., Craig, W. Y., and Cooper, A. D. (1985) Regulation of rat biliary cholesterol secretion by agents that alter intrahepatic cholesterol metabolism: evidence for a distinct biliary precursor pool. J. Clin. Invest. 76, 1773-1781
30. Bjorkhem, I., Andersson, O., Diczfalusy, U., Sevastik, B., Xiu, R. J., Duan, C., and Lund, E. (1994) Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. U. S. A. 91, 8592-8596
31. Honda, A., Salen, G., Matsuzaki, Y., Batta, A. K., Xu, G., Leitersdorf, E., Tint, G. S., Erickson, S. K., Tanaka, N., and Shefer, S. (2001) Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/α mice but not in cerebrotendinous xanthomatosis. J. Biol. Chem. 276, 34579-34585
32. Verrips, A., Wevers, R. A., Van Engelen, B. G., Keyser, A., Wolthers, B. G., Barkhof, F., Stalenhoef, A., De Graaf, R., Janssen-Zijlstra, F., Van Spreeken, A., and Gabreels, F. J. (1999) Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. Metabolism 48, 233-238